Research

This year's m4 Award goes to the team led by physician PD Dr. Dr. Peter Dietrich. The team receives 500,000 euros for its iLivE project to develop an RNAi therapy that can be used to treat liver metastases.

A multidisciplinary team of scientists at FAU and Erlangen University Hospital is researching diagnostic and treatment options for the gynecological disease endometriosis. The Bavarian State Ministry of Health, Care, and Prevention is funding this project with three million euros.

Further proof of the strength of FAU as a location for cutting-edge research: Physicist Prof. Dr. Maria Chekhova and chemist Prof. Dr. Sjoerd Harder have each been awarded one of the coveted ERC Advanced Grants. The grants raise funding of around 2.5 million euros each for five years.

The German Research Foundation (DFG) is funding a new research training group at FAU that is investigating modern functional materials and thus making a major contribution to their efficient use in sustainable technologies such as photovoltaics, batteries and hydrogen.

In future, the production of bioactive molecules and drugs could do without external enzyme or metal catalysts. Chemists at FAU have developed a process in which an organoautocatalyst formed in situ enables the chemical synthesis of bioactive cyclic amine compounds with high efficiency under mild conditions.

Artificial intelligence (AI) algorithms are increasingly being used in medical diagnostics. But in many areas, their potential is still barely being exploited. A cooperation project between FAU's UKER and Gravina Hospital in Caltagirone (Italy) demonstrates that there is another way.

DFG funding for semiconductor development and bowel cancer research Major success for FAU: The German Research Foundation (DFG) has awarded funding for two new collaborative research centers at Friedrich-Alexander-Universität Erlangen-Nürnberg – one in semiconductor research and the second in cance...

Symmetry is a basic characteristic of most multicellular animals. However, asymmetry prevails in the cell division of embryonic cells. An FAU team has developed a working model that explains the molecular mechanism by which the protein anillin controls the asymmetry in the constriction of the mother cell.